Podcast: Cannaweek E15 – Investing in the EU
Cannaweek Episode 15 – Investing in the EU (with Stuart Forbes and Rahul Bhushan)
In this episode, host Heather Wicklein talks with the Co-Founders of United Kingdom based Rize ETF, Rahul Bhushan and Stuart Forbes and New Frontier Data‘s Chief Knowledge Officer, John Kagia. They discuss the state of the investment landscape in Europe and how the emergence of ETF’s and thematic investing has impacted the European Cannabis industry.
FLWR: The Rize Medical Cannabis and Life Sciences UCITS ETF seeks to track the Foxberry Medical Cannabis & Life Sciences Index. The objective of the Index is to provide exposure to companies involved in the global medical cannabis and cannabis-related life sciences sectors, with a focus on companies in the biotechnology/pharma and hemp and cannabidiol (CBD) sectors. The Index excludes companies that are considered to be either non-compliant with state and federal laws in the countries in which they operate and/or directly involved in the production and/or distribution of cannabis and/or cannabis-derived products containing more than hemp-defined levels of tetrahydrocannabinol (THC) for the recreational consumer market.
Capital at Risk Warning: An investment in the Fund(s) involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. The Funds may be registered or otherwise approved for distribution to the public in one or more European jurisdictions. Investors should continue to consider the terms of investment in any Fund (or Share Class thereof) carefully and seek professional investment advice before taking any decision to invest in such Fund (or Share Class thereof).